MENU
ACHL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Achilles Therapeutics (ACHL) Ownership - Who owns Achilles Therapeutics?
Profile
Industry
N/A
Address
245 Hammersmith Road
Phone
+44 2081544600
Employees
242
Web
https://www.achillestx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
41.86M
P/E Ratio
N/A
Total Cash
86.05M
Projected Growth
N/A
Total Debt
3.62M
Revenue
N/A
Risk (Beta)
1.78
Dividend Yield
N/A
Total Cash/Share
2.09
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ACHL
Capitalization
41.9M
P/E Ratio
N/A
Risk (Beta)
1.78
Dividend Yield
N/A
Total Cash
86.1M
Total Cash/Share
2.09
Total Debt
3.62M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
103M
P/B Ratio
0.39
Cash Flow
N/A
Earnings
-1.66
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
54K
Current Ratio
6.04
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-67.33M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-44.88
Shares Held By Institutions
23.8M
Shares Outstanding - Current
41.1M
Total Liabilities
19.5M
Total Volume MTD
N/A
Value
1
Gain YTD
10.360
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
245 Hammersmith Road
Phone
+44 2081544600
Employees
242
Web
https://www.achillestx.com